Firefly Neuroscience (NASDAQ:AIFF) vs. Nutanix (NASDAQ:NTNX) Critical Contrast

Nutanix (NASDAQ:NTNX) and Firefly Neuroscience (NASDAQ:AIFF) are both computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, profitability, analyst recommendations, institutional ownership and valuation.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Nutanix and Firefly Neuroscience, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nutanix	0	3	12	0	2.80
Firefly Neuroscience	0	0	0	0	0.00

Nutanix presently has a consensus target price of $79.50, indicating a potential upside of 12.72%. Given Nutanix’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Nutanix is more favorable than Firefly Neuroscience.

Valuation and Earnings

This table compares Nutanix and Firefly Neuroscience”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nutanix	$2.23 billion	8.48	-$124.78 million	($0.35)	-201.51
Firefly Neuroscience	$7.98 million	3.39	-$2.03 million	N/A	N/A

Firefly Neuroscience has lower revenue, but higher earnings than Nutanix.

Profitability

This table compares Nutanix and Firefly Neuroscience’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nutanix	-3.54%	-12.28%	3.30%
Firefly Neuroscience	-73.72%	-276.50%	-133.02%

Risk and Volatility

Nutanix has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500. Comparatively, Firefly Neuroscience has a beta of 3.06, suggesting that its stock price is 206% more volatile than the S&P 500.

Insider and Institutional Ownership

85.3% of Nutanix shares are held by institutional investors. Comparatively, 5.0% of Firefly Neuroscience shares are held by institutional investors. 6.8% of Nutanix shares are held by insiders. Comparatively, 8.4% of Firefly Neuroscience shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Nutanix beats Firefly Neuroscience on 9 of the 12 factors compared between the two stocks.

About Nutanix

Nutanix, Inc. engages in the provision of a cloud platform leveraging web-scale engineering and consumer-grade design. It operates through the following geographic segments: United States, Europe, the Middle East, Africa, Asia Pacific, and Other Americas. The firm also provides software solutions and cloud services to customers’ enterprise infrastructure. The company was founded by Dheeraj Pandey, Ajeet Singh, and Mohit Aron in 2009 and is headquartered in San Jose, CA.

About Firefly Neuroscience

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.